# Nasdaq, Inc.: Form 10-Q for the period ended Sep 30, 2026

- Company: [Nasdaq, Inc.](/companies/ndaq.md) (CIK 1120193)
- Form: 10-Q
- Filed: 2026-10-22
- Accepted by EDGAR: Oct 22, 2026, 14:03 ET
- Period: 2026-09-30
- Accession: 0001120193-26-000020
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1120193/000112019326000020/ndaq-20260930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1120193/000112019326000020/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-07-01 to 2026-09-30 | $2.39bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2026-01-01 to 2026-09-30 | $7.06bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-07-01 to 2026-09-30 | $912.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2026-01-01 to 2026-09-30 | $2.67bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2026-07-01 to 2026-09-30 | $1.48bn | us-gaap:GrossProfit |
| Gross profit | 9 months, 2026-01-01 to 2026-09-30 | $4.39bn | us-gaap:GrossProfit |
| Operating income | 3 months, 2026-07-01 to 2026-09-30 | $732.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2026-01-01 to 2026-09-30 | $2.10bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2026-07-01 to 2026-09-30 | $86.0m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months, 2026-01-01 to 2026-09-30 | $259.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2026-07-01 to 2026-09-30 | $162.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2026-01-01 to 2026-09-30 | $466.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-07-01 to 2026-09-30 | $540.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2026-01-01 to 2026-09-30 | $1.57bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-07-01 to 2026-09-30 | $0.96 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2026-01-01 to 2026-09-30 | $2.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-07-01 to 2026-09-30 | $0.97 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2026-01-01 to 2026-09-30 | $2.78 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-07-01 to 2026-09-30 | 563,313,521 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2026-01-01 to 2026-09-30 | 567,574,489 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2026-01-01 to 2026-09-30 | $1.92bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2026-01-01 to 2026-09-30 | $199.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2026-01-01 to 2026-09-30 | $500.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2026-01-01 to 2026-09-30 | $1.23bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-09-30 | $365.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-09-30 | $4.53bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-09-30 | $27.38bn | us-gaap:Assets |
| Current liabilities | at 2026-09-30 | $4.52bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-09-30 | $15.38bn | us-gaap:Liabilities |
| Long-term debt | at 2026-09-30 | $8.47bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2026-09-30 | $269.0m | us-gaap:DebtCurrent |
| Short-term borrowings | at 2026-09-30 | $269.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2026-09-30 | $12.00bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 64,110 characters.

### Financial Condition and Results of Operations

The following discussion and analysis of the financial

condition and results of operations of Nasdaq should be read

in conjunction with our condensed consolidated financial

statements and related notes included in this Form 10-Q.

Certain percentages and per share amounts herein may not

sum or recalculate due to rounding.

### EXECUTIVE OVERVIEW

Nasdaq is a leading technology platform that powers the

world’s economies. We architect the infrastructure of the

world’s most modern markets, power the innovation

economy, and build trust in the financial system. We

empower economic opportunity by designing and deploying

advanced technology, data, and intelligence solutions that

enable our clients to capture opportunities, navigate risk, and

strengthen resilience.

Our organizational structure aligns our businesses with the

foundational shifts that are driving the evolution of the global

financial system. We manage, operate and provide our

products and services in three business segments: Capital

Access Platforms, Financial Technology and Market

Services.

### Third Quarter 2026 Highlights and Recent Developments

- During the third quarter, Nasdaq welcomed 15 new

operating companies on the U.S. exchanges, raising $32

billion in proceeds, including 8 of the 10 largest operating

company IPOs, contributing to a 79% win rate for the

quarter.

- Index had a record $141 billion in net inflows over the

trailing twelve months, including $49 billion in the third

quarter. End-of-period ETP AUM was $1.2 trillion and

average ETP AUM over the third quarter was $1.1 trillion,

both setting new records. Nasdaq launched 32 new Index

products in the third quarter, including 16 international

products and 10 products in the institutional annuity space.

- Financial Technology delivered strong ARR and double-

digit revenue growth in each subdivision for the third

consecutive quarter. Financial Technology delivered 16%

revenue growth and 18% ARR growth. During the third

quarter of 2026, Nasdaq signed 54 new clients, 5 cross-

sells, and 135 upsells.

- Market Services set a new record in third quarter net

revenues benefitting from higher industry volumes across

U.S. options and European equities and strong performance

in U.S. cash equities, which achieved higher market share

and near record capture rate.

### Macroeconomic environment

Our business performance can be positively or negatively

impacted by a number of factors, including general economic

conditions, the accelerated pace of technological change, the

geopolitical environment, current or expected inflation,

interest rate fluctuations, the threat or imposition of broad-

based tariffs, market volatility, changes in investment

patterns and priorities, regulatory changes, pandemics and

other factors that are generally beyond our control. For

example, higher overall U.S. trading volumes for the nine

months ended September 30, 2026 compared with the same

period in 2025 led to an increase in our U.S. equities options

and U.S. cash equities revenues. Market factors also

contributed to higher valuations in Nasdaq Indices and higher

overall volumes in Index derivatives. To the extent that

global or national economic conditions weaken and result in

slower growth or recessions, our business may be negatively

impacted.

30

**Nasdaq’s Operating Results**

The following tables summarize our financial performance

for the three and nine months ended September 30, 2026

compared to the same periods in 2025. For a detailed

discussion of our results of operations, see “Segment

Operating Results” below.

*(in millions, except per share amounts)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Revenues less transaction-based expenses | $1,481 $1,315 | 12.6% |
| Operating expenses | 749 729 | 2.7% |
| Operating income | $732 $586 | 24.9% |
| Net income attributable to Nasdaq | $540 $423 | 27.8% |
| Diluted earnings per share | $0.96 $0.73 | 31.3% |
| Cash dividends declared per common share | $0.31 $0.27 | 14.8% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions, except per share amounts)** |  |
| Revenues less transaction-based expenses | $4,388 $3,857 | 13.8% |
| Operating expenses | 2,287 2,155 | 6.1% |
| Operating income | $2,101 $1,702 | 23.5% |
| Net income attributable to Nasdaq | $1,566 $1,270 | 23.4% |
| Diluted earnings per share | $2.76 $2.19 | 25.9% |
| Cash dividends declared per common share | $0.89 $0.78 | 14.1% |

In countries with currencies other than the U.S. dollar,

revenues and expenses are translated using monthly average

exchange rates. Impacts on our revenues less transaction-

based expenses and operating income associated with

fluctuations in foreign currency are discussed in more detail

under “Item 3. Quantitative and Qualitative Disclosures

About Market Risk.”

The following chart summarizes our ARR (in millions):

\* In the chart above, Other ARR totaled $42 million for the

third quarter of 2025 and included Solovis, Nasdaq Metrio

and Nasdaq Fund Secondaries.

ARR for a given period is the current annualized value

derived from subscription contracts with a defined contract

value. This excludes contracts that are not recurring, are one-

time in nature, or where the contract value fluctuates based

on defined metrics. ARR is currently one of our key

performance metrics to assess the health and trajectory of our

recurring business. ARR does not have any standardized

definition and is therefore unlikely to be comparable to

similarly titled measures presented by other companies. ARR

should be viewed independently of revenue and deferred

revenue and is not intended to be combined with or to replace

either of those items. For AxiomSL and Calypso recurring

revenue contracts, the amount included in ARR is consistent

with the amount that we invoice the customer during the

current period. Additionally, for AxiomSL and Calypso

recurring revenue contracts that include annual values that

increase over time, we include in ARR only the annualized

value of components of the contract that are considered

active as of the date of the ARR calculation. We do not

include the future committed increases in the contract value

as of the date of the ARR calculation. ARR is not a forecast

and the active contracts at the end of a reporting period used

in calculating ARR may or may not be extended or renewed

by our customers.

31

The ARR chart includes:

- Capital Access Platforms
- Proprietary market data subscriptions and annual listing fees within our Data & Listing Services business.
- Index data subscriptions and guaranteed minimum on futures contracts within our Index business.
- Subscription contracts under our Workflow & Insights business.
- Financial Technology
- Subscription contracts excluding non-recurring professional services.
- Other primarily includes ARR related to our Solovis business that was divested in October 2025 as well as Nasdaq Metrio and Nasdaq Fund Secondaries, which were each divested in the third quarter of 2026.

The following chart summarizes our quarterly annualized

SaaS revenues for September 30, 2026 and 2025 (in

millions):

\* In the chart above, Other SaaS totaled $40 million for 3Q25

included Solovis, Nasdaq Metrio and Nasdaq Fund

Secondaries.

### SEGMENT OPERATING RESULTS

The following tables present our revenues by segment:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Capital Access Platforms | $641 $534 | 20.2% |
| Financial Technology | 529 457 | 15.8% |
| Market Services | 1,221 967 | 26.2% |
| Other revenues | 2 21 | (90.9)% |
| Total revenues | $2,393 $1,979 | 20.9% |
| Transaction rebates | (623) (658) | (5.3)% |
| Brokerage, clearance and exchange fees | (289) (6) | N/M |
| Total revenues less transaction-based expenses | $1,481 $1,315 | 12.6% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Capital Access Platforms | $1,820 $1,552 | 17.2% |
| Financial Technology | 1,585 1,352 | 17.2% |
| Market Services | 3,640 3,208 | 13.5% |
| Other revenues | 18 63 | (71.6)% |
| Total revenues | $7,063 $6,175 | 14.4% |
| Transaction rebates | (2,059) (1,882) | 9.4% |
| Brokerage, clearance and exchange fees | (616) (436) | 41.3% |
| Total revenues less transaction-based expenses | $4,388 $3,857 | 13.8% |

N/M Not meaningful

32

The following charts present our Capital Access Platforms,

Financial Technology and Market Services segments as a

percentage of our total revenues, less transaction-based

expenses.

### Capital Access Platforms

The following tables present revenues and ARR from our

Capital Access Platforms segment:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Data & Listing Services | $224 $204 | 9.8% |
| Index | 286 206 | 38.9% |
| Workflow & Insights | 131 124 | 6.1% |
| Total Capital Access Platforms | $641 $534 | 20.2% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Data & Listing Services | $655 $594 | 10.2% |
| Index | 778 595 | 30.8% |
| Workflow & Insights | 387 363 | 6.4% |
| Total Capital Access Platforms | $1,820 $1,552 | 17.2% |

|  | As of September 30, 2026 | 2025 |
| --- | ---: | ---: |
| ARR (in millions) | $1,411 | $1,303 |

33

### Data & Listing Services Revenues

The following tables present key drivers from our Data &

Listing Services business:

| IPOs | Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| The Nasdaq Stock Market | 46 | 76 |
| Operating company | 15 | 46 |
| SPACs | 31 | 30 |
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 7 | 2 |
| Total new listings |  |  |
| The Nasdaq Stock Market | 167 | 205 |
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 8 | 4 |
|  | **Nine Months Ended September 30,** |  |
| IPOs | **2026** | **2025** |
| The Nasdaq Stock Market | 177 | 218 |
| Operating company | 56 | 129 |
| SPACs | 121 | 89 |
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 20 | 12 |
| Total new listings |  |  |
| The Nasdaq Stock Market | 531 | 569 |
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 28 | 19 |
|  | **As of September 30,** |  |
| Number of listed companies | **2026** | **2025** |
| The Nasdaq Stock Market | 4,726 | 4,359 |
| Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic | 1,103 | 1,133 |
| ARR (in millions) | $813 | $743 |

In the tables above:

- The number of total listed companies on The Nasdaq Stock

Market as of September 30, 2026 and 2025 included 1,292

and 1,000 ETPs, respectively.

- IPOs, new listings (which includes IPOs) and total listed

companies for exchanges that comprise Nasdaq Nordic and

Nasdaq Baltic represent companies listed on the Nasdaq

Nordic and Nasdaq Baltic exchanges and companies listed

on the alternative markets of Nasdaq First North.

Data & Listing Services revenues increased for the three and

nine months ended September 30, 2026, compared with the

same periods in 2025, primarily due to new data sales to new

and existing clients, pricing and usage, and increased revenue

from annual and initial listing fees due to new listings,

partially offset by the impact of prior year delistings and roll-

off of prior period amortization of initial listing fees. The

increase in the nine months ended September 30, 2026 also

included a favorable impact from changes in foreign currency

rates.

### Index Revenues

The following table presents key drivers from our Index

business:

|  | As of or Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| Number of licensed ETPs | 487 | 439 |
| **TTM change in period end ETP AUM tracking Nasdaq indices (in billions)** |  |  |
| Beginning balance | $829 | $600 |
| Net inflows | 141 | 91 |
| Net appreciation | 190 | 138 |
| Ending balance | $1,160 | $829 |
| Quarterly average ETP AUM tracking Nasdaq indices (in billions) | $1,108 | $777 |
| ARR (in millions) | $89 | $81 |

In the table above, TTM represents trailing twelve months.

Index revenues increased for the three and nine months ended

September 30, 2026, compared with the same periods in

2025, primarily due to higher average AUM in exchange

traded products linked to Nasdaq indices and higher volume

based revenues.

### Workflow & Insights Revenues

The following table presents key drivers from our Workflow

& Insights business:

*(in millions)*

|  | As of or Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| ARR | $509 | $479 |
| Quarterly annualized SaaS revenues | 440 | 410 |

Workflow & Insights revenues increased for the three and

nine months ended September 30, 2026, compared with the

same periods in 2025, primarily due to an increase in

analytics revenues, largely driven by eVestment and Nasdaq

Data Link sales growth.

34

### Financial Technology

The following tables present revenues from our Financial

Technology segment:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Financial Crime Management Technology | $103 $84 | 22.9% |
| Regulatory Technology | 123 109 | 12.9% |
| Capital Markets Technology | 303 264 | 14.7% |
| Total Financial Technology | $529 $457 | 15.8% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Financial Crime Management Technology | $294 $241 | 21.9% |
| Regulatory Technology | 361 315 | 14.8% |
| Capital Markets Technology | 930 796 | 16.7% |
| Total Financial Technology | $1,585 $1,352 | 17.2% |

### Financial Crime Management Technology Revenues

The following table presents key drivers for our Financial

Crime Management Technology business:

*(in millions)*

|  | As of or Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| ARR and Quarterly annualized SaaS revenues | $375 | $316 |

Financial Crime Management Technology revenues

increased for the three and nine months ended September 30,

2026, compared with the same periods in 2025, primarily due

to higher subscription revenues from new and existing clients

and higher professional services revenues.

### Regulatory Technology Revenues

The following table presents key drivers for our Regulatory

Technology business:

*(in millions)*

|  | As of or Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| ARR | $443 | $389 |
| Quarterly annualized SaaS revenues | 271 | 213 |

Regulatory Technology revenues increased for the three and

nine months ended September 30, 2026, compared with the

same periods in 2025, primarily due to increased subscription

revenues from our AxiomSL and Surveillance solutions

primarily driven by price increases and upsells to existing

clients and revenues from new clients. The increase in the

nine months ended September 30, 2026 also included a

favorable impact from changes in foreign currency rates.

### Capital Markets Technology Revenues

The following table presents key drivers for our Capital

Markets Technology business:

*(in millions)*

|  | As of or Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| ARR | $1,136 | $957 |
| Quarterly annualized SaaS revenues | 181 | 153 |

Capital Markets Technology revenues increased for the three

and nine months ended September 30, 2026 compared with

the same periods in 2025. The increase was primarily due to

higher revenues from data center expansion, including a

change in pricing structure, increased subscription revenues

across all businesses driven by upsells to existing clients and

revenues from new clients, partially offset by lower

professional services revenues. For the nine months ended

September 30, 2026 the increase was also driven by higher

Calypso upfront license revenues.

### Market Services

The following tables present revenues from our Market

Services segment:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Market Services | $1,221 $967 | 26.2% |
| Transaction-based expenses: |  |  |
| Transaction rebates | (623) (658) | (5.3)% |
| Brokerage, clearance and exchange fees | (289) (6) | N/M |
| Total Market Services, net | $309 $303 | 1.9% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Market Services | $3,640 $3,208 | 13.5% |
| Transaction-based expenses: |  |  |
| Transaction rebates | (2,059) (1,882) | 9.4% |
| Brokerage, clearance and exchange fees | (616) (436) | 41.3% |
| Total Market Services, net | $965 $890 | 8.5% |

N/M Not meaningful

35

The following tables present net revenues by product from

our Market Services segment:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| U.S. Equity Derivative Trading | $110 $124 | (11.8)% |
| Cash Equity Trading | 144 127 | 13.7% |
| U.S. Tape plans | 33 33 | 2.3% |
| Other | 22 19 | 10.8% |
| Total Market Services, net | $309 $303 | 1.9% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| U.S. Equity Derivative Trading | $352 $346 | 1.8% |
| Cash Equity Trading | 442 381 | 15.8% |
| U.S. Tape plans | 100 103 | (2.6)% |
| Other | 71 60 | 19.9% |
| Total Market Services, net | $965 $890 | 8.5% |

In the tables above, Other includes Nordic fixed income

trading & clearing, Nordic derivatives and Canadian cash

equities trading.

### U.S. Equity Derivative Trading

The following tables present total revenues, transaction-based

expenses, and total revenues less transaction-based expenses

as well as key drivers from our U.S. Equity Derivative

Trading business:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| U.S. Equity Derivative Trading Revenues | $420 $436 | (3.9)% |
| Section 31 fees | 33 — | —% |
| Transaction-based expenses: |  |  |
| Transaction rebates | (309) (312) | (1.0)% |
| Section 31 fees | (33) — | —% |
| Brokerage and clearance fees | (1) — | 249.9% |
| U.S. Equity Derivative Trading Revenues, net | $110 $124 | (11.8)% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| U.S. Equity Derivative Trading Revenues | $1,313 $1,271 | 3.4% |
| Section 31 fees | 68 47 | 44.2% |
| Transaction-based expenses: |  |  |
| Transaction rebates | (959) (922) | 4.0% |
| Section 31 fees | (68) (47) | 44.2% |
| Brokerage and clearance fees | (2) (3) | (18.4)% |
| U.S. Equity Derivative Trading Revenues, net | $352 $346 | 1.8% |

Section 31 fees are recorded as U.S. equity derivative and

U.S. cash equity trading revenues with a corresponding

amount recorded in transaction-based expenses. We are

assessed these fees from the SEC and pass them through to

our customers in the form of incremental fees. Pass-through

fees can increase or decrease due to rate changes by the SEC,

our percentage of the overall industry volumes processed on

our systems, and differences in actual dollar value traded.

Section 31 fees increased for the three and nine months ended

September 30, 2026, compared with the same periods in

2025, primarily due to a higher average SEC fee rate. Since

the amount recorded in revenues is equal to the amount

recorded as Section 31 fees, there is no impact on our net

revenues.

36

| U.S. equity options | Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| Total industry average daily volume (in millions) | 63.8 | 55.8 |
| Nasdaq PHLX matched market share | 10.4% | 10.4% |
| The Nasdaq Options Market matched market share | 3.2% | 2.5% |
| Nasdaq Texas Options matched market share | 1.2% | 1.6% |
| Nasdaq ISE Options matched market share | 6.6% | 7.0% |
| Nasdaq GEMX Options matched market share | 3.2% | 3.5% |
| Nasdaq MRX Options matched market share | 3.5% | 3.5% |
| Total matched market share executed on Nasdaq’s exchanges | 28.1% | 28.5% |
|  | **Nine Months Ended September 30,** |  |
| U.S. equity options | **2026** | **2025** |
| Total industry average daily volume (in millions) | 64.3 | 54.0 |
| Nasdaq PHLX matched market share | 11.4% | 9.7% |
| The Nasdaq Options Market matched market share | 2.8% | 3.9% |
| Nasdaq Texas Options matched market share | 1.3% | 1.7% |
| Nasdaq ISE Options matched market share | 6.4% | 6.8% |
| Nasdaq GEMX Options matched market share | 3.3% | 3.9% |
| Nasdaq MRX Options matched market share | 3.9% | 3.0% |
| Total matched market share executed on Nasdaq’s exchanges | 29.1% | 29.0% |

U.S. equity derivative trading revenues and U.S. equity

derivative trading revenues, net decreased for the three

months ended September 30, 2026, compared with the same

period in 2025, primarily due to lower capture, partially

offset by higher industry trading volumes. U.S. equity

derivative trading revenues and U.S. equity derivative trading

revenues, net increased for the nine months ended September

30, 2026, compared with the same period in 2025, primarily

due to higher industry trading volumes, partially offset by

lower capture.

Transaction rebates, in which we credit a portion of the

execution charge to the market participant, decreased for the

three months ended September 30, 2026, compared with the

same period in 2025, primarily due to lower rebate capture

rate, partially offset by higher industry trading volumes.

### Cash Equity Trading Revenues

The following tables present total revenues, transaction-based

expenses, and total revenues less transaction-based expenses

as well as key drivers and other metrics from our Cash Equity

Trading business:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Cash Equity Trading Revenues | $456 $471 | (3.1)% |
| Section 31 fees | 251 — | N/M |
| Transaction-based expenses: |  |  |
| Transaction rebates | (308) (338) | (8.9)% |
| Section 31 fees | (251) — | N/M |
| Brokerage and clearance fees | (4) (6) | (30.0)% |
| Cash equity trading revenues, net | $144 $127 | 13.7% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Cash Equity Trading Revenues | $1,535 $1,340 | 14.5% |
| Section 31 fees | 531 367 | 44.8% |
| Transaction-based expenses: |  |  |
| Transaction rebates | (1,078) (940) | 14.8% |
| Section 31 fees | (531) (367) | 44.8% |
| Brokerage and clearance fees | (15) (19) | (18.2%) |
| Cash equity trading revenues, net | $442 $381 | 15.8% |

N/M Not meaningful

See the discussion above for an explanation of Section 31

fees for the three and nine months ended September 30, 2026

compared with the same periods in 2025.

37

| Total U.S.-listed securities | Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| Total industry average daily share volume (in billions) | 16.9 | 17.6 |
| Matched share volume (in billions) | 157.5 | 158.6 |
| The Nasdaq Stock Market matched market share | 14.1% | 13.7% |
| Nasdaq Texas matched market share | 0.3% | 0.3% |
| Nasdaq PSX matched market share | 0.1% | 0.1% |
| Total matched market share executed on Nasdaq’s exchanges | 14.5% | 14.1% |
| Market share reported to the FINRA/Nasdaq Trade Reporting Facility | 47.7% | 47.6% |
| Total market share | 62.2% | 61.7% |
| Nasdaq Nordic and Nasdaq Baltic securities |  |  |
| Average daily number of equity trades executed on Nasdaq’s exchanges | 653,117 | 627,568 |
| Total average daily value of shares traded (in billions) | $5.3 | $4.5 |
| Total market share executed on Nasdaq’s exchanges | 75.0% | 72.8% |
|  | **Nine Months Ended September 30,** |  |
| Total U.S.-listed securities | **2026** | **2025** |
| Total industry average daily share volume (in billions) | 19.0 | 17.2 |
| Matched share volume (in billions) | 525.7 | 454.4 |
| The Nasdaq Stock Market matched market share | 14.4% | 13.8% |
| Nasdaq Texas matched market share | 0.3% | 0.3% |
| Nasdaq PSX matched market share | 0.1% | 0.1% |
| Total matched market share executed on Nasdaq’s exchanges | 14.8% | 14.2% |
| Market share reported to the FINRA/Nasdaq Trade Reporting Facility | 46.5% | 47.7% |
| Total market share | 61.3% | 61.9% |
| Nasdaq Nordic and Nasdaq Baltic securities |  |  |
| Average daily number of equity trades executed on Nasdaq’s exchanges | 730,953 | 736,829 |
| Total average daily value of shares traded (in billions) | $6.0 | $5.2 |
| Total market share executed on Nasdaq’s exchanges | 74.6% | 71.8% |

Cash equity trading revenues decreased for the three months

ended September 30, 2026, compared with the same period in

2025, primarily due to lower U.S. industry trading volumes

and lower U.S. gross capture rate, partially offset by higher

U.S. matched market share executed on Nasdaq's exchanges

and higher European trading volumes.

Cash equity trading revenues, net increased for the three

months ended September 30, 2026, compared with the same

period in 2025, primarily due to higher U.S. capture rate,

higher U.S. matched market share executed on Nasdaq's

exchanges and higher European trading volumes, partially

offset by lower U.S. industry trading volumes.

Cash equity trading revenues and Cash equity trading

revenues, net increased for the nine months ended September

30, 2026, compared with the same period in 2025, primarily

due to higher U.S. industry trading volumes and U.S. and

European matched market share executed on Nasdaq's

exchanges. The increase in cash equity trading revenues for

the nine months ended September 30, 2026 was partially

offset by lower capture rate.

Transaction rebates, in which we credit a portion of the

execution charge to the market participant, decreased for the

three months ended September 30, 2026, compared with the

same period in 2025, primarily due to lower industry trading

volumes, partially offset by higher U.S. matched market

share executed on Nasdaq’s exchanges. The increase for the

nine months ended September 30, 2026 is primarily driven

by higher industry trading volumes and higher U.S. matched

market share executed on Nasdaq’s exchanges, partially

offset by lower capture rate. For The Nasdaq Stock Market

and Nasdaq PSX, we credit a portion of the per share

execution charge to the market participant that provides the

liquidity, and for Nasdaq Texas, we credit a portion of the per

share execution charge to the market participant that takes the

liquidity.

### U.S. Tape Plans

The following tables present revenues from our U.S. Tape

plans business:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | --- | ---: |
| U.S. Tape plans | $33 $33 | 2.3% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| U.S. Tape plans | $100 $103 | (2.6)% |

U.S. Tape plans revenues remained relatively flat for the

three months ended September 30, 2026, compared with the

same period in 2025. The decrease for the nine months ended

September 30, 2026 is primarily due to lower audit revenues,

partially offset by an industry-wide adjustment in 2025.

38

### Other

Other includes Nordic fixed income trading and clearing,

Nordic derivatives and Canadian cash equities trading. The

following tables present revenues from our Other business:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | --- | ---: |
| Other | $22 $19 | 10.8% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Other | $71 $60 | 19.9% |

In the preceding tables, Other is presented net of Canadian

cash equity transaction rebates of $6 million and $7 million

for the three months ended September 30, 2026 and 2025,

respectively, and $22 million and $20 million for the nine

months ended September 30, 2026 and 2025, respectively.

Other revenues increased for the three and nine months ended

September 30, 2026, compared with the same periods in

2025, primarily due to an increase in Nordic fixed income

revenues driven by higher volumes. The increase for the nine

months ended September 30, 2026, compared with the same

period in 2025, was also due to an increase in Canadian cash

equity revenues.

### Other Revenues

For the three months ended September 30, 2026, Other

revenues related to our Nasdaq Metrio platform and our

sustainability advisory business that is in the process of being

wound down. For the nine months ended September 30,

2026, Other revenues also included our Nordic power futures

business and Nasdaq Fund Secondaries. For the three and

nine months ended September 30, 2025, Other revenues also

included our Solovis business. See Note 4, “Acquisitions and

Divestitures,” to the condensed consolidated financial

statements for further discussion.

### EXPENSES

### Operating Expenses

The following tables present our operating expenses:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Compensation and benefits | $379 $353 | 7.4% |
| Professional and contract services | 42 38 | 11.6% |
| Technology and communication infrastructure | 93 80 | 16.0% |
| Occupancy | 34 32 | 5.2% |
| General, administrative and other | 2 22 | (92.9)% |
| Marketing and advertising | 17 13 | 33.2% |
| Depreciation and amortization | 165 158 | 4.8% |
| Regulatory | 11 12 | (10.3)% |
| Merger and strategic initiatives | 6 9 | (38.3)% |
| Restructuring charges | — 12 | (100.0)% |
| **Total operating expenses** | $749 $729 | 2.7% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Compensation and benefits | $1,118 $1,033 | 8.2% |
| Professional and contract services | 124 112 | 10.2% |
| Technology and communication infrastructure | 264 236 | 11.9% |
| Occupancy | 103 90 | 13.4% |
| General, administrative and other | 54 51 | 5.8% |
| Marketing and advertising | 61 41 | 48.5% |
| Depreciation and amortization | 496 471 | 5.3% |
| Regulatory | 29 41 | (28.3)% |
| Merger and strategic initiatives | 14 53 | (73.7)% |
| Restructuring charges | 24 27 | (7.9)% |
| **Total operating expenses** | $2,287 $2,155 | 6.1% |

39

The increase in compensation and benefits expense for the

three and nine months ended September 30, 2026, compared

with the same periods in 2025, was primarily driven by

higher incentive compensation driven by strong revenue

execution.

Headcount, including employees of non-wholly owned

consolidated subsidiaries, was 9,593 employees as of

September 30, 2026 and 9,625 employees as of September

30, 2025.

Professional and contract services expense increased for the

three and nine months ended September 30, 2026, compared

with the same periods in 2025, primarily due to higher legal

fee accruals.

Technology and communication infrastructure expense

increased for the three and nine months ended September 30,

2026, compared with the same periods in 2025, primarily due

to increased investment in technology, particularly our cloud

initiatives and software licensing.

Occupancy expense increased for the three and nine months

ended September 30, 2026, compared with the same periods

in 2025, primarily due to colocation data center expansion.

General, administrative and other expense decreased for the

three months ended September 30, 2026, compared with the

same period in 2025 primarily due to a favorable legal

settlement. The increase for the nine months ended

September 30, 2026 compared with the same period in 2025

was primarily due to a gain on extinguishment of debt

recorded in the first quarter of 2025 and other individually

immaterial increases, partially offset by a favorable legal

settlement in the third quarter of 2026.

Marketing and advertising expense increased for the three

and nine months ended September 30, 2026, compared with

the same periods in 2025, primarily due to a strengthening

IPO environment.

Depreciation and amortization expense increased for the

three and nine months ended September 30, 2026, compared

with the same periods in 2025, due to increased depreciation

of capitalized software projects.

Regulatory expense decreased for the three and nine months

ended September 30, 2026, compared with the same periods

in 2025, primarily due to lower CAT operating costs.

We have pursued various strategic initiatives and completed

acquisitions and divestitures in recent years, which have

resulted in expenses which would not have otherwise been

incurred. These expenses generally include integration costs,

as well as legal, due diligence and other third-party

transaction costs and vary based on the size and frequency of

the activities described above. For the three and nine months

ended September 30, 2026, these costs included amounts

associated with various strategic initiative costs. For the three

and nine months ended September 30, 2025, these costs

primarily included amounts associated with the transfer of

open positions in our Nordic power futures business, Adenza

integration costs and other strategic initiative costs.

Restructuring charges decreased for the three and nine

months ended September 30, 2026, compared with the same

periods in 2025, primarily due to the completion of our

restructuring program. See Note 19, “Restructuring Charges,”

to the condensed consolidated financial statements for further

discussion.

### Non-Operating Income and Expenses

The following tables present our non-operating income and

expenses:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Interest income | $10 $8 | 17.0% |
| Interest expense | (86) (87) | (1.5)% |
| Net interest expense | (76) (79) | (3.5)% |
| Net loss on divestitures | (4) (2) | 100.0% |
| Other income (loss) | 11 — | N/M |
| Net income from unconsolidated investees | 38 24 | 59.7% |
| Total non-operating expense | $(31) $(57) | (45.2)% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Interest income | $23 $32 | (27.2)% |
| Interest expense | (259) (279) | (7.2)% |
| Net interest expense | (236) (247) | (4.6)% |
| Net gain on divestitures | 84 37 | 126.4% |
| Other income (loss) | (4) — | N/M |
| Net income from unconsolidated investees | 86 73 | 16.4% |
| Total non-operating expense | $(70) $(137) | (48.9)% |

N/M Not meaningful

40

The following tables present our interest expense:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Interest expense on debt | $83 $84 | (1.2)% |
| Accretion of debt issuance costs and debt discount | 2 2 | (8.1)% |
| Other fees | 1 1 | (17.2)% |
| Interest expense | $86 $87 | (1.5)% |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Interest expense on debt | $250 $269 | (7.1)% |
| Accretion of debt issuance costs and debt discount | 7 8 | (9.4)% |
| Other fees | 2 2 | (10.0)% |
| Interest expense | $259 $279 | (7.2)% |

Interest income increased for the three months ended

September 30, 2026 compared with the same period in 2025,

primarily due to a higher average cash balance and a

favorable interest rate environment. Interest income

decreased for the nine months ended September 30, 2026,

compared with the same period in 2025, primarily due to a

lower average cash balance, partially offset by a favorable

interest rate environment.

Interest expense decreased for the three and nine months

ended September 30, 2026, compared with the same periods

in 2025, primarily due to lower outstanding debt following

the repayment of our 2025 Notes and the partial repurchases

of several series of outstanding senior unsecured notes in

2025.

For the three months ended September 30, 2026 the Net loss

on divestitures relates to the net impact of the sale of the

Nasdaq Metrio platform and related customer contracts and

the sale of Nasdaq Fund Secondaries. Net gain on

divestitures for the nine months ended September 30, 2026

and September 30, 2025 primarily relates to the divestiture of

our Nordic power futures business, net of costs to sell, which

for the nine months ended September 30, 2026 is partially

offset by the net loss described above for the three months

ended September 30, 2026. For the nine months ended

September 30, 2025, this also includes a gain on the sale of

our Nasdaq Risk Modelling for Catastrophes business, net of

costs to sell. See Note 4, “Acquisitions and Divestitures,” to

the condensed consolidated financial statements for further

discussion of these transactions.

Other income (loss) primarily represents realized and

unrealized gains and losses from strategic investments related

to our corporate venture program. For the nine months ended

September 30, 2026, this also includes the impairment of

intangible assets related to customer relationships and

licenses associated with the wind-down of our Nordic power

futures business. See “Acquired Intangible Assets,” of Note

5, “Goodwill and Acquired Intangible Assets,” and “Equity

Investments,” of Note 6, “Investments,” to the condensed

consolidated financial statements for further discussion of

these transactions.

Net income from unconsolidated investees primarily relates

to income recognized from our equity method investment in

OCC. See “Equity Investments,” of Note 6, “Investments,” to

the condensed consolidated financial statements for further

discussion.

### Tax Matters

The following tables present our income tax provision and

effective tax rate:

*(in millions)*

|  | Three Months Ended September 30, 2026 2025 | Percentage Change |
| --- | ---: | ---: |
| Income tax provision | $162 $106 | 51.0% |
| Effective tax rate | 22.9% 20.0% |  |
|  | **Nine Months Ended September 30,** | **Percentage Change** |
|  | **2026** **2025** |  |
|  | **(in millions)** |  |
| Income tax provision | $466 $296 | 57.0% |
| Effective tax rate | 22.9% 18.9% |  |

For further discussion of our tax matters, see Note 16,

“Income Taxes,” to the condensed consolidated financial

statements.

### NON-GAAP FINANCIAL MEASURES

In addition to disclosing results determined in accordance

with U.S. GAAP, we also provide non-GAAP net income

and non-GAAP diluted earnings per share in this Quarterly

Report on Form 10-Q. Management uses this non-GAAP

information internally, along with U.S. GAAP information,

in evaluating our performance and in making financial and

operational decisions. We believe our presentation of these

measures provides investors with greater transparency and

supplemental data relating to our financial condition and

results of operations. In addition, we believe the presentation

of these measures is useful to investors for period-to-period

comparisons of our ongoing operating performance.

41

These measures are not in accordance with, or an alternative

to, U.S. GAAP, and may be different from non-GAAP

measures used by other companies. In addition, other

companies, including companies in our industry, may

calculate such measures differently, which reduces their

usefulness as comparative measures. Investors should not

rely on any single financial measure when evaluating our

business. This non-GAAP information should be considered

as supplemental in nature and is not meant as a substitute for

our operating results in accordance with U.S. GAAP. We

recommend investors review the U.S. GAAP financial

measures included in this Quarterly Report on Form 10-Q,

including our condensed consolidated financial statements

and the notes thereto. When viewed in conjunction with our

U.S. GAAP results and the accompanying reconciliation, we

believe these non-GAAP measures provide greater

transparency and a more complete understanding of factors

affecting our business than U.S. GAAP measures alone.

We understand that analysts and investors regularly rely on

non-GAAP financial measures, such as non-GAAP net

income and non-GAAP diluted earnings per share, to assess

operating performance. We use non-GAAP net income and

non-GAAP diluted earnings per share because they highlight

trends more clearly in our business that may not otherwise be

apparent when relying solely on U.S. GAAP financial

measures, since these measures eliminate from our results

specific financial items that have less bearing on our ongoing

operating performance.

The following tables present reconciliations between U.S.

GAAP net income and diluted earnings per share and non-

GAAP net income and diluted earnings per share:

*(in millions, except per share amounts)*

|  | Three Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| **U.S. GAAP net income attributable to Nasdaq** | $540 | $423 |
| Non-GAAP adjustments: |  |  |
| Amortization expense of acquired intangible assets | 121 | 122 |
| Merger and strategic initiatives expense | 6 | 9 |
| Restructuring charges | — | 12 |
| Net loss on divestitures | 4 | 2 |
| Net income from unconsolidated investees | (38) | (24) |
| Legal and regulatory matters | (16) | 1 |
| Other (income) loss | (11) | 4 |
| Total non-GAAP adjustments | $66 | $126 |
| Non-GAAP tax adjustments | (14) | (32) |
| Other tax adjustments | (4) | (6) |
| **Total non-GAAP adjustments, net of tax** | $48 | $88 |
| **Non-GAAP net income attributable to Nasdaq** | $588 | $511 |
| **U.S. GAAP effective tax rate** | 22.9% | 20.0% |
| Total adjustments from non- GAAP tax rate | 0.4% | 2.0% |
| **Non-GAAP effective tax rate** | 23.3% | 22.0% |
| Weighted-average common shares outstanding for diluted earnings per share | 563.3 | 579.0 |
| **U.S. GAAP diluted earnings per share** | $0.96 | $0.73 |
| Total adjustments from non- GAAP net income | 0.08 | 0.15 |
| **Non-GAAP diluted earnings per share** | $1.04 | $0.88 |

42

*(in millions, except per share amounts)*

|  | Nine Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| **U.S. GAAP net income attributable to Nasdaq** | $1,566 | $1,270 |
| Non-GAAP adjustments: |  |  |
| Amortization expense of acquired intangible assets | 364 | 365 |
| Merger and strategic initiatives expense | 14 | 53 |
| Restructuring charges | 24 | 27 |
| Gain on extinguishment of debt | — | (19) |
| Net gain on divestitures | (84) | (37) |
| Net income from unconsolidated investees | (86) | (73) |
| Legal and regulatory matters | (3) | 3 |
| Other loss | 9 | 6 |
| Total non-GAAP adjustments | $238 | $325 |
| Non-GAAP tax adjustments | (58) | (84) |
| Other tax adjustments | (4) | (51) |
| **Total non-GAAP adjustments, net of tax** | $176 | $190 |
| **Non-GAAP net income attributable to Nasdaq** | $1,742 | $1,460 |
| **U.S. GAAP effective tax rate** | 22.9% | 18.9% |
| Total adjustments from non- GAAP tax rate | 0.4% | 3.9% |
| **Non-GAAP effective tax rate** | 23.3% | 22.8% |
| Weighted-average common shares outstanding for diluted earnings per share | 567.6 | 579.3 |
| **U.S. GAAP diluted earnings per share** | $2.76 | $2.19 |
| Total adjustments from non- GAAP net income | 0.31 | 0.33 |
| **Non-GAAP diluted earnings per share** | $3.07 | $2.52 |

We believe that excluding the above items, described further

below, from the non-GAAP net income provides a more

meaningful analysis of Nasdaq’s ongoing operating

performance and comparisons in Nasdaq’s performance

between periods:

- *Amortization expense of acquired intangible assets:* We

amortize intangible assets acquired in connection with

various acquisitions. Intangible asset amortization expense

can vary from period to period due to episodic acquisitions

completed, rather than from our ongoing business

operations. As such, if intangible asset amortization is

included in performance measures, it is more difficult to

assess the day-to-day operating performance of the

businesses and the relative operating performance of the

businesses between periods.

- *Merger and strategic initiatives expense:* We have pursued

various strategic initiatives and completed acquisitions and

divestitures in recent years that have resulted in expenses

which would not have otherwise been incurred. The

frequency and the amount of such expenses vary

significantly based on the size, timing and complexity of

the transactions. These expenses primarily include

integration costs, as well as legal, due diligence and other

third-party transaction costs. For the three and nine months

ended September 30, 2026, these costs included amounts

associated with various strategic initiative costs. For the

three and nine months ended September 30, 2025, these

costs primarily included amounts associated with the

transfer of open positions in our Nordic power futures

business, Adenza integration costs and other strategic

initiative costs.

- *Restructuring charges:* See Note 19, “Restructuring

Charges,” to the condensed consolidated financial

statements for further discussion of this program.

- *Gain on extinguishment of debt:* This gain is recorded in

general, administrative and other expense in the Condensed

Consolidated Statements of Income.

- *Net (gain) loss on divestitures:* For the three months ended

September 30, 2026, the Net loss on divestitures relates to

the net impact of the sale of the Nasdaq Metrio platform

and related customer contracts and the sale of Nasdaq Fund

Secondaries. Net gain on divestitures for the nine months

ended September 30, 2026 and September 30, 2025

primarily relates to the divestiture of our Nordic power

futures business, which for the nine months ended

September 30, 2026 is partially offset by the net loss

described above for the three months ended September 30,

2026\. For the nine months ended September 30, 2025, this

also includes a gain on the sale of our Nasdaq Risk

Modelling for Catastrophes business. See Note 4,

“Acquisitions and Divestitures,” to the condensed

consolidated financial statements for further discussion of

these transactions.

- *Net income from unconsolidated investees*: We exclude our

share of the earnings and losses of our equity method

investments. This provides a more meaningful analysis of

Nasdaq’s ongoing operating performance or comparisons

in Nasdaq’s performance between periods. See “Equity

Investments,” of Note 6, “Investments,” to the condensed

consolidated financial statements for further discussion.

- *Legal and regulatory matters:* For the three and nine

months ended September 30, 2026, this includes a

favorable legal settlement, recorded in general,

administrative and other expense in the Condensed

Consolidated Statements of Income. For the three and nine

months ended September 30, 2026 and 2025, this also

includes accruals relating to certain legal matters, which

are recorded in professional and contract services in the

Condensed Consolidated Statements of Income.

43

- *Other income (loss):* For the three and nine months ended

September 30, 2026 and 2025, other items primarily

include net gains and losses from strategic investments

entered into through our corporate venture program. For

the nine months ended September 30, 2026, this also

includes intangible assets impairments of customer

relationships and licenses relating to the wind-down of our

Nordic power futures business. The net effect of these

items is included in other income (loss) in our Condensed

Consolidated Statements of Income. See “Acquired

Intangible Assets,” of Note 5, “Goodwill and Acquired

Intangible Assets,” and “Equity Investments,” of Note 6,

“Investments,” to the condensed consolidated financial

statements for further discussion of these transactions.

- *Non-GAAP tax adjustments:* The non-GAAP adjustment to

the income tax provision for all periods primarily includes

the tax impact of each non-GAAP adjustment.

- *Other tax adjustments:* For the nine months ended

September 30, 2025, other tax adjustments reflect a tax

benefit related to payments made to certain former Adenza

employees and the release of the prior years' reserves

following a favorable audit settlement.

### LIQUIDITY AND CAPITAL RESOURCES

Historically, we have funded our operating activities and met

our commitments through cash generated by operations,

augmented by the periodic issuance of debt. Currently, our

cost and availability of funding remain healthy. We continue

to prudently assess our capital deployment strategy through

balancing internal investments, debt repayments, and

shareholder return activity, including dividends and share

repurchases, and potential acquisitions.

We expect that our current cash and cash equivalents

combined with cash flows provided by operating activities,

supplemented with our borrowing capacity and access to

additional financing, including our revolving credit facility

and our commercial paper program, provides us additional

flexibility to meet our ongoing obligations and the capital

deployment strategic actions described above, while allowing

us to invest in activities and product development that

support the long-term growth of our operations.

Principal factors that could affect the availability of our

internally generated funds include:

- deterioration of our revenues in any of our business

segments;

- changes in regulatory and working capital requirements;

and

- an increase in our expenses.

Principal factors that could affect our ability to obtain cash

from external sources include:

- operating covenants contained in our credit facilities that

limit our total borrowing capacity;

- credit rating downgrades, which could limit our access to

additional debt;

- a significant decrease in the market price of our common

stock; and

- volatility or disruption in the public debt and equity

markets.

The following table summarizes selected measures of our

liquidity and capital resources:

*(in millions)*

|  | September 30, 2026 | December 31, 2025 |
| --- | ---: | ---: |
| Working capital | $15 | $42 |
| Cash and cash equivalents | 365 | 604 |
| Short-term investments | 151 | 28 |

### Working Capital

The decrease in working capital from December 31, 2025 to

September 30, 2026, excluding default funds and margin

deposits, as the corresponding assets and liabilities are both

equal and offsetting, is primarily due to a decrease in current

assets partially offset by a decrease in current liabilities.

Decrease in current assets was primarily due to:

- lower cash and cash equivalents,
- lower restricted cash primarily due to the movement of

regulatory capital to short-term investments with original

maturities longer than 90 days, and

- lower other current assets, partially offset by
- higher receivables, net primarily due to an increase in

Section 31 fee rate, higher average AUM-driven Index

receivables, and timing of billings, and

- an increase in short-term investments at fair value.

Decrease in current liabilities was primarily due to:

- a decrease in short-term debt, see “Debt obligations” below

for further discussion,

- a decrease in accrued personnel costs,
- a decrease in accounts payable and accrued expenses, and
- a decrease in other current liabilities, partially offset by
- increased Section 31 fees payable due to an increase in the

Section 31 fee rate, and

- higher deferred revenue due to timing of billings, primarily

relating to our annual listing fees.

### Cash and Cash Equivalents

Cash and cash equivalents includes all non-restricted cash in

banks and highly liquid investments with original maturities

of 90 days or less at the time of purchase. The balance

retained in cash and cash equivalents is a function of

anticipated or possible short-term cash needs, prevailing

interest rates, our investment policy, and alternative

investment choices. As of September 30, 2026 and December

31, 2025, our cash and cash equivalents of $365 million and

$604 million, respectively, were primarily invested in bank

deposits and money market funds.

44

### Repatriation of Cash

Our cash and cash equivalents held outside of the U.S. in

various foreign subsidiaries totaled $208 million as of

September 30, 2026 and $280 million as of December 31,

2025\. The remaining balance held in the U.S. totaled $157

million as of September 30, 2026 and $324 million as of

December 31, 2025.

### Restricted Cash and Cash Equivalents

Restricted cash and cash equivalents, which was $28 million

as of September 30, 2026 and $210 million as of December

31, 2025, is restricted from withdrawal due to a contractual

or regulatory requirement or not available for general use and

as such is classified as restricted in the Condensed

Consolidated Balance Sheets. The decrease in this balance as

of September 30, 2026 is primarily due to more regulatory

capital being held in investments with original maturities

greater than 90 days and less than one year that are classified

as short-term investments in the Condensed Consolidated

Balance Sheets as of September 30, 2026. Capital held for

regulatory purposes is invested based on prevailing market

rates and our investment strategy and may be held in

investments with original maturities of 90 days or less that

qualify as cash equivalents and are included in restricted cash

and cash equivalents or in investments with original

maturities greater than 90 days and less than one year that are

classified as short-term investments in the Condensed

Consolidated Balance Sheets.

#### Cash Flow Analysis

The following table summarizes the changes in cash flows:

*(in millions)*

| Net cash provided by (used in): | Nine Months Ended September 30, 2026 | 2025 |
| --- | ---: | ---: |
| Operating activities | $1,921 | $1,630 |
| Investing activities | 366 | (462) |
| Financing activities | (4,982) | (2,386) |

### Net Cash Provided by Operating Activities

Net cash provided by operating activities primarily consists

of net income adjusted for certain non-cash items, including,

but not limited to, depreciation and amortization expense,

expense associated with share-based compensation, net

income from unconsolidated investees, net gain on

divestitures and the effects of changes in working capital.

Refer to the above discussion regarding changes in working

capital.

Net cash provided by operating activities increased $291

million for the nine months ended September 30, 2026

compared with the same period in 2025. The increase was

primarily driven by higher net income and an increase in

adjustments to net income, partially offset by changes in

working capital, as discussed above.

### Net Cash Provided by (Used in) Investing Activities

Net cash provided by (used in) investing activities increased

for the nine months ended September 30, 2026 compared

with the same period in 2025. This was primarily driven by

higher proceeds from net sales and redemption of

investments related to default funds and margin deposits of

$1,199 million, which does not impact Nasdaq's cash, cash

equivalents, restricted cash or restricted cash equivalents as it

relates to customer funds. The increase is also driven by

lower other investing activities, which primarily represents

purchases of minority investments made through our

corporate venture program, of $60 million and higher

proceeds from divestitures, net of cash divested of $40

million. The increase was partially offset by a net increase in

purchases of securities of $291 million, primarily due to

more regulatory capital being invested in investments with

original maturities greater than 90 days, purchases of

corporate debt securities of $100 million, an acquisition of a

business, net of cash and cash equivalents acquired of $58

million and purchases of property and equipment of $22

million.

See Note 4, “Acquisitions and Divestitures,” and Note 6,

“Investments,” to the condensed consolidated financial

statements for further discussion.

### Net Cash Used in Financing Activities

Net cash used in financing activities increased for the nine

months ended September 30, 2026 compared with the same

period in 2025 primarily driven by higher outflows of cash

from the default funds and margin deposits of $2,218 million,

which does not impact Nasdaq's cash, cash equivalents,

restricted cash or restricted cash equivalents as it relates to

customer funds, increases in repurchases of common stock of

$896 million and an increase in dividends paid of $52

million. These increases were partially offset by a decrease in

repayment of debt of $295 million and issuance of

commercial paper, net of $269 million.

See Note 8, “Debt Obligations,” to the condensed

consolidated financial statements for further discussion of our

debt obligations.

See “Default Fund Contributions and Margin Deposits” of

Note 14, “Clearing Operations,” for further discussion of

these balances.

See “Share Repurchase Program,” and “Cash Dividends on

Common Stock,” of Note 11, “Nasdaq Stockholders’

Equity,” to the condensed consolidated financial statements

for further discussion of our share repurchase program and

cash dividends declared and paid on our common stock.

### Short-term Investments

Our short-term investments totaled $151 million as of

September 30, 2026 and $28 million as of December 31,

2025\. Of these securities, $134 million as of September 30,

2026 and $18 million as of December 31, 2025 are assets

primarily utilized to meet regulatory capital requirements,

mainly for our clearing operations at Nasdaq Clearing. The

45

increase in this balance as of September 30, 2026 is primarily

due to more capital held for regulatory purposes being

invested in investments with original maturities greater than

90 days, classified as short-term investments. This increase

was partially offset by a decrease in regulatory capital

requirements due to the sale of our Nordic power futures

business. See Restricted Cash and Cash Equivalents above

and Note 6, “Investments,” to the condensed consolidated

financial statements for further discussion.

### Regulatory Capital Requirements

### Clearing Operations Regulatory Capital Requirements

We are required to maintain minimum levels of regulatory

capital for the clearing operations of Nasdaq Clearing. The

level of regulatory capital required to be maintained is

dependent upon many factors, including market conditions

and creditworthiness of the counterparty. As of September

30, 2026, our required regulatory capital of $104 million was

primarily comprised of European government debt securities

that are included in short-term investments in the Condensed

Consolidated Balance Sheets.

### Broker-Dealer Net Capital Requirements

Our broker-dealer subsidiaries, Nasdaq Execution Services

and Nasdaq Capital Markets Advisory, are subject to

regulatory requirements intended to ensure their general

financial soundness and liquidity. These requirements

obligate these subsidiaries to comply with minimum net

capital requirements. As of September 30, 2026, the

combined required minimum net capital was immaterial and

the combined excess capital totaled $14 million, substantially

all of which is held in cash and cash equivalents in the

Condensed Consolidated Balance Sheets. The required

minimum net capital is included in restricted cash and cash

equivalents in the Condensed Consolidated Balance Sheets.

### Nordic and Baltic Exchange Regulatory Capital

### Requirements

The entities that operate trading venues in the Nordic and

Baltic countries are each subject to local regulations and are

required to maintain regulatory capital intended to ensure

their general financial soundness and liquidity. As of

September 30, 2026, our required regulatory capital of $40

million was primarily invested in European government debt

securities that are included in short-term investments in the

Condensed Consolidated Balance Sheets and cash and cash

equivalents, which is included in restricted cash and cash

equivalents in the Condensed Consolidated Balance Sheets.

### Other Capital Requirements

We operate several other businesses which are subject to

local regulation and are required to maintain certain levels of

regulatory capital. As of September 30, 2026, other required

regulatory capital of $13 million, primarily related to Nasdaq

Central Securities Depository, was primarily invested in

European government debt securities that are included in

short-term investments in the Condensed Consolidated

Balance Sheets and cash and cash equivalents, which is

included in restricted cash and cash equivalents in the

Condensed Consolidated Balance Sheets.

### Equity and dividends

### Share Repurchase Program

See “Share Repurchase Program,” of Note 11, “Nasdaq

Stockholders’ Equity,” to the condensed consolidated

financial statements for further discussion of our share

repurchase program, including our ASR agreements.

### Cash Dividends on Common Stock

The following table presents our quarterly cash dividends

paid per common share on our outstanding common stock:

|  | 2026 | 2025 |
| --- | ---: | ---: |
| First quarter | $0.27 | $0.24 |
| Second quarter | 0.31 | 0.27 |
| Third quarter | 0.31 | 0.27 |
| Total | $0.89 | $0.78 |

See “Cash Dividends on Common Stock,” of Note 11,

“Nasdaq Stockholders’ Equity,” to the condensed

consolidated financial statements for further discussion of the

dividends.

46

### Debt Obligations

Our outstanding debt obligations, by contractual maturity, at September 30, 2026 are as follows (in U.S. Dollar millions):

n U.S. Notes n Euro Notes

As of and for the nine months ended September 30, 2026, the

weighted average interest rate on our debt obligations was

approximately 3.7%. This rate can fluctuate based on changes

in foreign currency exchange rates and changes in the amount

and duration of outstanding debt. See “Foreign Currency

Exchange Rate Risk” below for further discussion on

hedging associated with our Euro Notes. In June 2026,

Nasdaq amended and restated our existing $1.25 billion five-

year revolving credit facility, with a new maturity date of

June 30, 2031, and increased the borrowing capacity to

$1.50 billion. In addition to the 2026 Revolving Credit

Facility, we also have other credit facilities primarily to

support our Nasdaq Clearing operations in Europe, as well as

to provide a cash pool credit line.

As of September 30, 2026, we were in compliance with the

covenants of all of our debt obligations.

See Note 8, “Debt Obligations,” to the condensed

consolidated financial statements for further discussion of our

debt obligations.

### CONTRACTUAL OBLIGATIONS AND CONTINGENT

### COMMITMENTS

Nasdaq had no significant changes to our contractual

obligations and contingent commitments from those

disclosed in “Part II. Item 7. Management’s Discussion and

Analysis of Financial Condition and Results of Operations”

in our Annual Report on Form 10-K that was filed with the

SEC on February 12, 2026.

### OFF-BALANCE SHEET ARRANGEMENTS

For discussion of off-balance sheet arrangements see:

- Note 14, “Clearing Operations,” to the condensed

consolidated financial statements for further discussion of

our non-cash default fund contributions and margin

deposits received for clearing operations; and

- Note 17, “Commitments, Contingencies and Guarantees,”

to the condensed consolidated financial statements for

further discussion of:

- Guarantees issued and credit facilities available;
- Other guarantees; and
- Routing brokerage activities.

## Market risk

As filed, 14,975 characters.

### Market Risk

As a result of our operating, investing and financing

activities, we are exposed to market risks such as interest rate

risk and foreign currency exchange rate risk. We are also

exposed to credit risk as a result of our normal business

activities.

We have implemented policies and procedures to measure,

manage, monitor and report risk exposures, which are

reviewed regularly by management and the board of

directors. We identify risk exposures and monitor and

manage such risks on a daily basis.

47

We perform sensitivity analyses to determine the effects of

market risk exposures. We may use derivative instruments

solely to hedge financial risks related to our financial

positions or risks that are incurred during the normal course

of business. We do not use derivative instruments for

speculative purposes.

### Interest Rate Risk

We are subject to the risk of fluctuating interest rates in the

normal course of business. Our exposure to market risk for

changes in interest rates relates primarily to our short-term

investments and debt obligations, which are discussed below.

We may enter into transactions that expose us to interest rate

risk, for which we may utilize interest rate derivatives

agreements to manage that risk.

### Short-Term Investments

As of September 30, 2026, our investment portfolio was

primarily comprised of highly rated European government

debt securities, which pay a fixed rate of interest. These

securities are subject to interest rate risk and the fair value of

these securities will decrease if market interest rates increase.

The impact of an immediate increase to market interest rates,

uniformly, by a hypothetical 100 basis points from levels as

of September 30, 2026, would not have a material impact on

our financial statements.

### Debt Obligations

As of September 30, 2026, the majority of our outstanding

debt obligations are fixed-rate obligations. Interest rates on

certain tranches of notes are subject to adjustment to the

extent our debt rating is downgraded below investment grade,

as further discussed in Note 8, “Debt Obligations,” to the

condensed consolidated financial statements. While changes

in interest rates will have no impact on the interest we pay on

fixed-rate obligations, we are exposed to changes in interest

rates as a result of the borrowings under our 2026 Revolving

Credit Facility, as this facility has a variable interest rate. We

may also be exposed to changes in interest rates if there are

amounts outstanding from the sale of commercial paper

under our commercial paper program, which have variable

interest rates. As of September 30, 2026, we have $269

million outstanding under our commercial paper program. A

hypothetical 100 basis points increase in interest rates on our

outstanding commercial paper would not have a material

impact on our financial statements.

### Foreign Currency Exchange Rate Risk

We are subject to foreign currency exchange rate risk. Our

primary transactional exposure to foreign currency

denominated revenues less transaction-based expenses and

operating income for the three and nine months ended

September 30, 2026 is presented in the following tables. The

tables below do not include the offsetting impact of our

hedging programs.

*(in millions, except currency rate)*

*Three Months Ended September 30, 2026*

|  | Euro | Swedish Krona | Canadian Dollar | Other Foreign Currencies | U.S. Dollar |
| --- | ---: | ---: | ---: | ---: | ---: |
| Average FX rate to the U.S. dollar | 1.151 | 0.104 | 0.715 | # | N/A |
| Percentage of revenues less transaction- based expenses | 6.5% | 3.1% | 0.6% | 3.1% | 86.7% |
| Percentage of operating income | 7.2% | (0.9)% | (5.2)% | (7.4)% | 106.3% |
| Impact of a 10% adverse currency fluctuation on revenues less transaction- based expenses | $(10) | $(5) | $(1) | $(5) | $— |
| Impact of a 10% adverse currency fluctuation on operating income | $(5) | $(1) | $(4) | $(5) | $— |

*(in millions, except currency rate)*

*Nine Months Ended September 30, 2026*

|  | Euro | Swedish Krona | Canadian Dollar | Other Foreign Currencies | U.S. Dollar |
| --- | ---: | ---: | ---: | ---: | ---: |
| Average FX rate to the U.S. dollar | 1.161 | 0.107 | 0.722 | # | N/A |
| Percentage of revenues less transaction- based expenses | 7.3% | 3.4% | 0.7% | 3.3% | 85.3% |
| Percentage of operating income | 9.6% | (1.6)% | (5.4)% | (7.2)% | 104.6% |
| Impact of a 10% adverse currency fluctuation on revenues less transaction- based expenses | $(32) | $(15) | $(3) | $(14) | $— |
| Impact of a 10% adverse currency fluctuation on operating income | $(20) | $(3) | $(11) | $(15) | $— |

#Represents multiple foreign currency rates.

N/ANot applicable.

48

The adverse impacts shown in the preceding tables should be

viewed individually by currency and not in aggregate, due to

the correlation between changes in exchange rates for certain

currencies.

We may use foreign exchange contracts to hedge a portion of

our forecasted foreign currency denominated revenues and

expenses in the normal course of business. We hedge these

cash flow exposures to reduce the risk that our earnings and

cash flows will be adversely affected by changes in exchange

rates. These foreign exchange contracts are carried at fair

value, with maturities that can range up to 18 months. We

record changes in fair value of these cash flow hedges of

foreign currency denominated revenue and expenses in

accumulated other comprehensive loss in the Condensed

Consolidated Balance Sheets, until the forecasted transaction

occurs. When the forecasted transaction affects earnings, or

in the event the underlying forecasted transaction does not

occur, or it becomes probable that it will not occur, we

reclassify the related gain or loss on the cash flow hedge to

revenue or operating expenses, as applicable. As of

September 30, 2026, the fair value of our derivatives

designated as cash flow hedging instruments are not material.

Our investments in foreign subsidiaries are exposed to

volatility in currency exchange rates through translation of

the foreign subsidiaries’ net assets or equity to U.S. dollars.

Substantially all of our foreign subsidiaries operate in

functional currencies other than the U.S. dollar. The financial

statements of these subsidiaries are translated into U.S.

dollars for consolidated reporting using a current rate of

exchange, with net gains or losses recorded in accumulated

other comprehensive loss in the Condensed Consolidated

Balance Sheets.

Our primary exposure to net assets in foreign currencies as of

September 30, 2026 is presented in the following table:

*(in millions)*

|  | Net Assets | Impact of a 10% Adverse Currency Fluctuation |
| --- | ---: | ---: |
| Swedish Krona | $3,053 | $(305) |
| Canadian Dollar | 132 | (13) |
| Norwegian Krone | 106 | (11) |
| Australian Dollar | 106 | (11) |
| British Pound | 77 | (8) |

In the table above, Swedish Krona includes goodwill of

$2,290 million and intangible assets, net of $459 million.

Our Euro Notes have been designated as a hedge of our net

investment in certain foreign subsidiaries to mitigate the

foreign exchange risk associated with certain investments in

these subsidiaries. Accordingly, the remeasurement of these

notes is recorded in accumulated other comprehensive loss in

the Condensed Consolidated Balance Sheets. See Note 8,

“Debt Obligations,” to the condensed consolidated financial

statements for further discussion. We enter into foreign

exchange contracts to hedge a portion of our net investment

in certain foreign subsidiaries. These foreign exchange

contracts are carried at fair value, with remaining maturities

ranging up to eight years, and reported as either an asset or

liability depending on their position as of the balance sheet

date, and accumulated other comprehensive loss in the

Condensed Consolidated Balance Sheets. The accumulated

gains and losses associated with these instruments will

remain in accumulated other comprehensive loss until the

foreign subsidiaries are sold or substantially liquidated, at

which point they will be reclassified into earnings.

### Credit Risk

Credit risk is the potential loss due to the default or

deterioration in credit quality of customers or counterparties.

We are exposed to credit risk from third parties, including

customers, counterparties and clearing agents. These parties

may default on their obligations to us due to bankruptcy, lack

of liquidity, operational failure or other reasons. We limit our

exposure to credit risk by evaluating the counterparties with

which we make investments and execute agreements. For our

investment portfolio, our objective is to invest in securities to

preserve principal while maximizing yields, without

significantly increasing risk. Credit risk associated with

investments is minimized substantially by ensuring that these

financial assets are placed with governments which have

investment grade ratings, well-capitalized financial

institutions and other creditworthy counterparties.

Our subsidiary, Nasdaq Execution Services, may be exposed

to credit risk due to the default of trading counterparties in

connection with the routing services it provides for our

trading customers. System trades in cash equities routed to

other market centers for members of our cash equity

exchanges are routed by Nasdaq Execution Services for

clearing to the NSCC. In this function, Nasdaq Execution

Services is to be neutral by the end of the trading day, but

may be exposed to intraday risk if a trade extends beyond the

trading day and into the next day, thereby leaving Nasdaq

Execution Services susceptible to counterparty risk in the

period between accepting the trade and routing it to the

clearinghouse. In this interim period, Nasdaq Execution

Services is not novating like a clearing broker but instead is

subject to the short-term risk of counterparty failure before

the clearinghouse enters the transaction. Once the

clearinghouse officially accepts the trade for novation,

Nasdaq Execution Services is legally removed from trade

execution risk. However, Nasdaq has membership

obligations to NSCC independent of Nasdaq Execution

Services’ arrangements.

Pursuant to the rules of the NSCC and Nasdaq Execution

Services’ clearing agreement, Nasdaq Execution Services is

liable for any losses incurred due to a counterparty or a

clearing agent’s failure to satisfy its contractual obligations,

either by making payment or delivering securities. Adverse

movements in the prices of securities that are subject to these

transactions can increase our credit risk. However, we believe

that the risk of material loss is limited, as Nasdaq Execution

Services’ customers are not permitted to trade on margin and

NSCC rules limit counterparty risk on self-cleared

transactions by establishing credit limits and capital deposit

requirements for all brokers that clear with NSCC.

49

Historically, Nasdaq Execution Services has never incurred a

liability due to a customer’s failure to satisfy its contractual

obligations as counterparty to a system trade. Credit

difficulties or insolvency, or the perceived possibility of

credit difficulties or insolvency, of one or more larger or

visible market participants could also result in market-wide

credit difficulties or other market disruptions.

We have credit risk related to transaction and subscription-

based revenues that are billed to customers on a monthly or

quarterly basis, in arrears. Our potential exposure to credit

losses on these transactions is represented by the receivable

balances in the Condensed Consolidated Balance Sheets. We

review and evaluate changes in the status of our

counterparties’ creditworthiness. Credit losses such as those

described above could adversely affect our consolidated

financial position and results of operations.

We also are exposed to credit risk through our clearing

operations with Nasdaq Clearing. See Note 14, “Clearing

Operations,” to the condensed consolidated financial

statements for further discussion. Our clearinghouse holds

material amounts of clearing member cash deposits, which

are held or invested primarily to provide security of capital

while minimizing credit, market and liquidity risks. While we

seek to achieve a reasonable rate of return, we are primarily

concerned with preservation of capital and managing the

risks associated with these deposits. As the clearinghouse

may remit to the members interest earned at prevailing

market rates, less a spread, this could include negative or

reduced yield due to market conditions. The following is a

summary of the risks associated with these deposits and how

these risks are mitigated.

- *Credit Risk:* When the clearinghouse has the ability to hold

cash collateral at a central bank, the clearinghouse utilizes

its access to the central bank system to minimize credit risk

exposures. When funds are not held at a central bank, we

seek to substantially mitigate credit risk by ensuring that

investments are primarily placed in large, highly rated

financial institutions, highly rated government debt

instruments and other creditworthy counterparties.

- *Liquidity Risk:* Liquidity risk is the risk a clearinghouse

may not be able to meet its payment obligations in the right

currency, in the right place and the right time. To mitigate

this risk, the clearinghouse monitors liquidity requirements

closely and maintains funds and assets in a manner which

minimizes the risk of loss or delay in the access by the

clearinghouse to such funds and assets. For example,

holding funds with a central bank where possible or

investing in highly liquid government debt instruments

serves to reduce liquidity risks.

- *Interest Rate Risk:* Interest rate risk is the risk that interest

rates rise causing the value of purchased securities to

decline. If we were required to sell securities prior to

maturity, and interest rates had risen, the sale of the

securities might be made at a loss relative to the latest

market price. Our clearinghouse seeks to manage this risk

by making short-term investments of members’ cash

deposits. In addition, the clearinghouse investment

guidelines allow for direct purchases or repurchase

agreements with short dated maturities of high quality

sovereign debt (for example, European government and

U.S. Treasury securities), central bank certificates and

multilateral development bank debt instruments.

- *Security Issuer Risk:* Security issuer risk is the risk that an

issuer of a security defaults on its payment when the

security matures. This risk is mitigated by limiting

allowable investments and collateral under reverse

repurchase agreements to high quality sovereign,

government agency or multilateral development bank debt

instruments.

## Controls and procedures

As filed, 1,022 characters.

### Disclosure Controls and Procedures

Nasdaq’s management, with the participation of Nasdaq’s

Chief Executive Officer, and Executive Vice President and

Chief Financial Officer, has evaluated the effectiveness of

Nasdaq’s disclosure controls and procedures (as defined in

Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act)

as of the end of the period covered by this report. Based upon

that evaluation, Nasdaq’s Chief Executive Officer and

Executive Vice President and Chief Financial Officer, have

concluded that, as of the end of such period, Nasdaq’s

disclosure controls and procedures are effective.

### Changes in Internal Control Over Financial Reporting

There have been no changes in Nasdaq’s internal control over

financial reporting (as defined in Rule 13a-15(f) and Rule

15d-15(f) under the Exchange Act) that occurred during the

quarter ended September 30, 2026 that have materially

affected, or are reasonably likely to materially affect,

Nasdaq’s internal control over financial reporting.

## Risk factors

As filed, 517 characters.

In addition to the other information set forth in this Quarterly

Report on Form 10-Q, you should carefully consider the

factors discussed under “Risk Factors” in our most recent

Form 10-K. These risks could materially and adversely affect

our business, financial condition and results of operations.

These risks and uncertainties are not the only ones facing us.

Additional risks and uncertainties not presently known to us

or that we currently believe to be immaterial may also

adversely affect our business.

Filed Oct 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001120193-26-000020. Last ingested by Listed: Nov 13, 2026, 16:21 ET. No prices; not investment advice.
